Compare OPK & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPK | ECPG |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 1.8B |
| IPO Year | 2011 | 1999 |
| Metric | OPK | ECPG |
|---|---|---|
| Price | $1.10 | $81.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.60 | ★ $77.33 |
| AVG Volume (30 Days) | ★ 2.1M | 290.2K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 287.14 |
| EPS | N/A | ★ 3.86 |
| Revenue | $606,879,000.00 | ★ $1,768,802,000.00 |
| Revenue This Year | N/A | $4.53 |
| Revenue Next Year | $4.24 | $4.76 |
| P/E Ratio | ★ N/A | $21.08 |
| Revenue Growth | N/A | ★ 34.37 |
| 52 Week Low | $0.98 | $35.68 |
| 52 Week High | $1.60 | $92.64 |
| Indicator | OPK | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 53.35 |
| Support Level | $0.98 | $54.39 |
| Resistance Level | $1.25 | $85.42 |
| Average True Range (ATR) | 0.04 | 3.48 |
| MACD | -0.00 | -0.82 |
| Stochastic Oscillator | 52.69 | 21.05 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.